Home Cart 0 Sign in  

[ CAS No. 70298-89-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 70298-89-4
Chemical Structure| 70298-89-4
Structure of 70298-89-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 70298-89-4 ]

Related Doc. of [ 70298-89-4 ]

Alternatived Products of [ 70298-89-4 ]

Product Details of [ 70298-89-4 ]

CAS No. :70298-89-4 MDL No. :MFCD00996248
Formula : C10H14N2O Boiling Point : -
Linear Structure Formula :- InChI Key :JCMMVFHXRDNILC-UHFFFAOYSA-N
M.W : 178.23 Pubchem ID :427059
Synonyms :

Calculated chemistry of [ 70298-89-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.71
TPSA : 41.99 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.82
Log Po/w (XLOGP3) : 1.9
Log Po/w (WLOGP) : 1.88
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 1.57
Consensus Log Po/w : 1.61

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.29
Solubility : 0.923 mg/ml ; 0.00518 mol/l
Class : Soluble
Log S (Ali) : -2.4
Solubility : 0.702 mg/ml ; 0.00394 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.23
Solubility : 0.104 mg/ml ; 0.000585 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.2

Safety of [ 70298-89-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 70298-89-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 70298-89-4 ]
  • Downstream synthetic route of [ 70298-89-4 ]

[ 70298-89-4 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 70298-89-4 ]
  • [ 273-70-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 3, p. 563 - 566
  • 2
  • [ 927-63-9 ]
  • [ 70298-89-4 ]
  • [ 253-72-5 ]
Reference: [1] Synlett, 2006, # 3, p. 379 - 382
  • 3
  • [ 70298-89-4 ]
  • [ 13534-98-0 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 11, p. 1505 - 1510
  • 4
  • [ 70298-89-4 ]
  • [ 88511-27-7 ]
Reference: [1] Patent: WO2004/111047, 2004, A2, . Location in patent: Page 25
  • 5
  • [ 70298-89-4 ]
  • [ 52334-53-9 ]
Reference: [1] European Journal of Medicinal Chemistry, 2005, vol. 40, # 1, p. 15 - 23
[2] Journal of Organic Chemistry, 1995, vol. 60, # 17, p. 5721 - 5725
  • 6
  • [ 504-24-5 ]
  • [ 3282-30-2 ]
  • [ 70298-89-4 ]
YieldReaction ConditionsOperation in experiment
95% With triethylamine In dichloromethane at 20℃; for 15 h; a)
Synthesis of 2,2-dimethyl-N-pyridin-4-yl-propionamide
4-pyridylamine (2 g, 21.3 mmol) was dissolved in dichloromethane (20 ml), and pyvaloyl chloride (3.1 ml, 25.6 mmol) and triethylamine (8.9 mg, 63.9 mmol) were added thereto in this order at room temperature dropwise.
The reaction solution was stirred at room temperature for 15 hours and the reaction was quenched by adding water.
The organic layer was extracted with ethyl acetate, and then the combined organic layer was washed with saturated saline solution (50 ml), dried over anhydrous sodium sulfate (Na2SO4), filtered and evaporated under reduced pressure.
The residue was purified by column chromatography on silica eluding with a solvent of dichloromethane: methanol=20:1.
The fractions containing the product were collected and evaporated to obtain the target compound as white solid (3.6 g, 95percent).
1H-NMR (CDCl3, 300 MHz); δ=8.47 (d, J=6.1 Hz, 2H), 7.79 (br s, 1H), 7.52 (d, J=6.0 Hz, 2H), 1.32 (s, 9H).
74% With triethylamine In dichloromethane Example 25A
2,2-dimethyl-N-pyridin-4-ylpropanamide
A mixture of 4-aminopyridine (10 g, 106 mmol) and pivaloyl chloride (12.9 g, 107 mmol) in 200 mL dichloromethane was cooled to 0° C. and treated slowly with triethylamine (10.9 g, 108 mmol), warmed to room temperature, stirred overnight, and diluted with water.
The aqueous layer was extracted three times with dichloromethane and the combined extracts were washed with brine, dried (Na2SO4), filtered, and concentrated.
The product was recrystallized from toluene to provide the desired product (14 g, 74percent).
74% With triethylamine In dichloromethane at 0 - 20℃; Example 25A
2,2-dimethyl-N-pyridin-4-ylpropanamide
A mixture of 4-aminopyridine (10 g, 106 mmol) and pivaloyl chloride (12.9 g, 107 mmol) in 200 mL dichloromethane was cooled to 0° C. and treated slowly with triethylamine (10.9 g, 108 mmol), warmed to room temperature, stirred overnight, and diluted with water.
The aqueous layer was extracted three times with dichloromethane and the combined extracts were washed with brine, dried (Na2SO4), filtered, and concentrated.
The product was recrystallized from toluene to provide the desired product (14 g, 74percent).
73% With triethylamine In dichloromethane at 0 - 20℃; for 2 h; EXAMPLES EXAMPLE 1: Preparation of 2, 2-Dimethyl-N-pyridinyl-propionamides 1A : 2, 2-Dimethyl-N-pyridin-4-yl-propionamide [081] Following procedures generally taught in J. A. Turner, J. Org. Chem. 1983, 48, 3401- 3408, a solution of pivaloyl chloride (13.5 mL, 110 mmol) in CH2C12 (20 mL) was slowly added to an ice-cold solution of 4-aminopyridine (9.41 g, 100 mmol) and triethylamine (17.4 mL, 125 mmol) in CH2C12 (150 mL). After addition was complete, the resulting mixture was warmed to room temperature and stirred for 2 h. The solution was poured into water, the CH2C12 layer was washed with dilute NaHC03, dried over Na2SO4, and evaporated to leave a light brown solid. Recrystallization from EtOAc/hexanes afforded the product as a white crystal, which was collected by vacuum filtration (13.03 g, 73percent). 1H NMR (400 MHz, CDC13) 8 8. 50 (d, J= 4.8 Hz, 2 H), 7.50 (d, J= 4.8 Hz, 2 H), 7.44 (br s, 1 H), 1. 33 (s, 9 H). MS (LR-APCI) calcd. for CloH1sN20 (M+H) 179.1 ; found 179.1.
73.9% With triethylamine In chloroform at 0 - 20℃; for 1.16667 h; To a stirred solution of 4-amino pyridine (A; 5 g, 53.12 mmol) in CHCI3 (200 mL) were added triethylamine (TEA or Et3N) (11.5 mL, 106.2 mmol) followed by pivaloyl chloride (7.15 mL, 69 mmol) dropwise at 0°C over a period of 10 minutes (min). The reaction mixture was warmed to RT and stirred for 1.5 hours (h). The progress of the reaction was monitored by thin layer chromatography (TLC). The reaction mixture was washed with saturated sodium bicarbonate (NaHC03) solution, dried over anhydrous Na2S04 and concentrated under reduced pressure. The obtained crude material was purified by silica gel column chromatography eluting with 10percent methanol (MeOH)/dichloromethane (CH2CI2) to afford B (7 g, 73.9percent) as an off-white solid. *H NMR (200 MHz, DMSO-de): δ 9.54 (bs, NH), 8.40 (d, J = 5.8 Hz, 2H), 7.67 (d, / = 6.4 Hz, 2H), 1.23 (s, 9H). MS (ESI): m/z 179 [M++l].
70% With triethylamine In dichloromethane at 0 - 20℃; for 3 h; To a solution of 1 .88 g (20.0 mmol, 1 eq.) of 4-aminopyridine and 3.6 mL (26.0 mmol, 1 .3 eq.) of triethylamine in 30 mL of DCM, cooled to 0°C, were added 2.7 mL (22.0 mmol, 1 .1 eq.) of trimethylacetyl chloride in 4 mL of DCM. After 2 hours, the mixture was stirred one hour at room temperature. Then, 40 mL of water were added. The aqueous layer was extracted with 20 mL of dichloromethane. The organic phase was washed with 20 mL of aqueous NaHC03, dried, filtered and concentrated. Recrystallisation in PE/EtOAc 8:1 provided 2.50 g (14.0 mmol, 70percent) of VII as a white solid. Rf=0.07 (PE/EtOAc 2:1 ). 1H NMR (300 MHz): δ = 8.46 (d, J = 5.5 Hz, 2 H), 7.73 (broad, 1 H), 7.49 (dd, J = 4.9 Hz, J = 1 .4 Hz, 2 H), 1 .30 (s, 9 H) ppm. 13C NMR (75 MHz): δ = 177.5, 150.7, 145.3, 1 13.9, 40.1 , 27.5 ppm
70% With triethylamine In dichloromethane at 0 - 20℃; for 3 h; To a solution of 1.88 g (20.0 mmol, 1 eq.) of 4-aminopyridine and 3.6 mL (26.0 mmol, 1 .3 eq.) of triethylamine in 30 mL of DCM, cooled to 0°C, were added 2.7 mL (22.0 mmol, 1 .1 eq.) of trimethylacetyl chloride in 4 mL of DCM. After 2 hours, the mixture was stirred one hour at room temperature. Then, 40 mL of water were added. The aqueous layer was extracted with 20 mL of dichloromethane. The organic phase was washed with 20 mL of aqueous NaHC03, dried, filtered and concentrated. Recrystallisation in PE/EtOAc 8:1 provided 2.50 g (14.0 mmol, 70percent) of VII as a white solid. Rf=0.07 (PE/EtOAc 2:1 ). 1H NMR (300 MHz): δ = 8.46 (d, J = 5.5 Hz, 2 H), 7.73 (broad, 1 H), 7.49 (dd, J = 4.9 Hz, J = 1.4 Hz, 2 H), 1.30 (s, 9 H) ppm. 13C NMR (75 MHz): δ = 177.5, 150.7, 145.3, 113.9, 40.1 , 27.5 ppm
68% With triethylamine In dichloromethane at 0 - 20℃; for 18 h; A solution of trimethyl acetyl chloride (32.5 mL, 0.264 mol) in dry dichloromethane (50 mL) was added drop wise over 1 h to a stirred suspension of 4-aminopyridine (22.60 g, EPO <DP n="50"/>""0.240 ffiotraπtf iethyf.sum.BMπfef41.8 mL, 0.300 mol) in dry dichloromethane (360 mL) at 0 0C under nitrogen. The ice bath was removed and the reaction allowed to warm to r.t. overnight. After 17 h, the pale brown mixture was poured into water (500 mL). The organic layer was separated and washed with a dilute aqueous solution of sodium hydrogen carbonate (400 mL). The organic layer was separated, dried over sodium sulfate, filtered and the solvent evaporated in vacuo. The crude solid was recrystallized from ethyl acetate (75 mL) / hexane (50 mL), washed with diethyl ether (2 x 10 mL) and air dried to yield N-(pyridin-4-yl)pivalamide (29.11 g, 68percent) as colourless plate like crystals. 1H NMR : δ (CDCl&3, 400 MHz) 1.33 (s, 9 H), 7.50 (d, J = 6 Hz, 2 H), 7.56 (br. s., I H), 8.49 (d, J = 6 Hz, 2 H).
66% With triethylamine In dichloromethane at 0 - 20℃; for 2.25 h; Step 1: A solution of trimethylacetylcholride (423 mg, 3.51 mmol, 1.1 eq) in dichloromethane was slowly added to an ice cooled solution of pyridin-4-amine (300 mg, 3.19 mmol) and triethylamine (0.56 mL, 3.98 mmol, 1.25 eq) of dichloromethane. The resulting mixture was stirred in and ice bath for 15 min and then at room temperature for 2 h and poured into water. The reaction mixture was washed with dilute NaHC03 dried over Na2S04, and evaporated. The crude was purified by column chromatography to give N-(pyridin-4-yl)piva.amide (377 mg, 66 percent).
66% With triethylamine In dichloromethane at 20℃; for 2.25 h; Cooling with ice Step 1:
A solution of trimethylacetylcholride (423 mg, 3.51 mmol, 1.1 eq) in dichloromethane was slowly added to an ice cooled solution of pyridin-4-amine (300 mg, 3.19 mmol) and triethylamine (0.56 mL, 3.98 mmol, 1.25 eq) of dichloromethane.
The resulting mixture was stirred in and ice bath for 15 min and then at room temperature for 2 h and poured into water.
The reaction mixture was washed with dilute NaHCO3 dried over Na2SO4, and evaporated.
The crude was purified by column chromatography to give N-(pyridin-4-yl)pivalamide (377 mg, 66percent).
40%
Stage #1: With triethylamine In dichloromethane at 0 - 20℃;
Stage #2: With sodium hydrogencarbonate In dichloromethane
A solution of pivaloyl chloride (13.4 g, 1 1 1 mmol) in DCM (20 mL) was slowly added to a cooled (0 °C) solution of pyridin-4-amine (10 g, 106 mmol) and triethylamine (26.7 g, 265 mmol) in DCM (80 mL). After addition, the icebath was removed and the resulting mixture was stirred at 20 °C for 6 hours. The mixture was poured into water (100 mL) and extracted with DCM (3 x 100 mL). The combined organic extract was washed with saturated NaHC03 solution (100 mL) and brine (100 mL), dried over MgS04, and concentrated under reduced pressure. The residue was re-crystallized from EtO Ac/petroleum ether to give the desired product as white crystals (7.9 g, 40percent yield). LCMS (ESI) m/z: 179.1 [M+H+] .

Reference: [1] Synthesis, 2009, # 13, p. 2267 - 2277
[2] Patent: US2011/28467, 2011, A1, . Location in patent: Page/Page column 16
[3] Chemistry - A European Journal, 2013, vol. 19, # 20, p. 6435 - 6442
[4] Molecules, 2003, vol. 8, # 9, p. 678 - 686
[5] European Journal of Medicinal Chemistry, 2005, vol. 40, # 1, p. 15 - 23
[6] Journal of Organic Chemistry, 1983, vol. 48, # 20, p. 3401 - 3408
[7] Patent: US2003/187026, 2003, A1,
[8] Patent: US6344/449, 2002, B1, . Location in patent: Example A3a)
[9] Patent: US6344449, 2002, B1, . Location in patent: Example A3a)
[10] Patent: US2003/199511, 2003, A1, . Location in patent: Page/Page column 24
[11] Patent: WO2005/56552, 2005, A1, . Location in patent: Page/Page column 20-21
[12] Patent: WO2014/117090, 2014, A1, . Location in patent: Page/Page column 88-89
[13] Patent: WO2014/198844, 2014, A1, . Location in patent: Page/Page column 17; 18
[14] Patent: WO2014/198848, 2014, A2, . Location in patent: Page/Page column 16; 17
[15] Patent: WO2006/66172, 2006, A1, . Location in patent: Page/Page column 48-49
[16] Patent: WO2013/13817, 2013, A1, . Location in patent: Page/Page column 143
[17] Patent: US2013/29961, 2013, A1, . Location in patent: Paragraph 0815
[18] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 8, p. 1867 - 1880
[19] Journal of Medicinal Chemistry, 2018, vol. 61, # 12, p. 5162 - 5186
[20] Patent: WO2012/35039, 2012, A1, . Location in patent: Page/Page column 76
[21] Tetrahedron Letters, 2007, vol. 48, # 27, p. 4707 - 4710
[22] Patent: US2003/171395, 2003, A1,
[23] Patent: EP1165555, 2003, B1,
[24] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 6, p. 2097 - 2102
[25] Journal of Medicinal Chemistry, 2016, vol. 59, # 15, p. 7138 - 7151
[26] Patent: WO2004/111047, 2004, A2, . Location in patent: Page 25
  • 7
  • [ 239137-59-8 ]
  • [ 70298-89-4 ]
Reference: [1] Patent: WO2013/170165, 2013, A1, . Location in patent: Page/Page column 88
  • 8
  • [ 75-98-9 ]
  • [ 70298-89-4 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 18, p. 4602 - 4605
  • 9
  • [ 13534-98-0 ]
  • [ 70298-89-4 ]
Reference: [1] Patent: WO2013/170165, 2013, A1,
  • 10
  • [ 3282-30-2 ]
  • [ 70298-89-4 ]
Reference: [1] Patent: WO2013/170165, 2013, A1,
  • 11
  • [ 70298-89-4 ]
  • [ 42373-30-8 ]
Reference: [1] Synthesis, 1999, # 6, p. 959 - 964
[2] Journal of Organic Chemistry, 1983, vol. 48, # 20, p. 3401 - 3408
[3] Patent: WO2013/13817, 2013, A1,
[4] Patent: US2013/29961, 2013, A1,
  • 12
  • [ 70298-89-4 ]
  • [ 113975-33-0 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 12, p. 2740 - 2744
  • 13
  • [ 70298-89-4 ]
  • [ 138116-34-4 ]
Reference: [1] Patent: WO2013/13817, 2013, A1,
[2] Patent: US2013/29961, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 70298-89-4 ]

Amides

Chemical Structure| 70298-88-3

[ 70298-88-3 ]

2,2-Dimehtyl-N-pyridin-3-yl-propionamide

Similarity: 0.87

Chemical Structure| 113975-33-0

[ 113975-33-0 ]

N-(3-Iodopyridin-4-yl)pivalamide

Similarity: 0.79

Chemical Structure| 3034-31-9

[ 3034-31-9 ]

N-Phenyl isonicotinicamide

Similarity: 0.75

Chemical Structure| 13602-82-9

[ 13602-82-9 ]

N-(2-Chloropyridin-4-yl)acetamide

Similarity: 0.73

Chemical Structure| 86847-59-8

[ 86847-59-8 ]

2,2-Dimethyl-N-pyridin-2-yl-propionamide

Similarity: 0.71

Amines

Chemical Structure| 70298-88-3

[ 70298-88-3 ]

2,2-Dimehtyl-N-pyridin-3-yl-propionamide

Similarity: 0.87

Chemical Structure| 113975-33-0

[ 113975-33-0 ]

N-(3-Iodopyridin-4-yl)pivalamide

Similarity: 0.79

Chemical Structure| 3034-31-9

[ 3034-31-9 ]

N-Phenyl isonicotinicamide

Similarity: 0.75

Chemical Structure| 13602-82-9

[ 13602-82-9 ]

N-(2-Chloropyridin-4-yl)acetamide

Similarity: 0.73

Chemical Structure| 69008-70-4

[ 69008-70-4 ]

N,N-Dipropylpyridin-4-amine

Similarity: 0.72

Related Parent Nucleus of
[ 70298-89-4 ]

Pyridines

Chemical Structure| 70298-88-3

[ 70298-88-3 ]

2,2-Dimehtyl-N-pyridin-3-yl-propionamide

Similarity: 0.87

Chemical Structure| 113975-33-0

[ 113975-33-0 ]

N-(3-Iodopyridin-4-yl)pivalamide

Similarity: 0.79

Chemical Structure| 3034-31-9

[ 3034-31-9 ]

N-Phenyl isonicotinicamide

Similarity: 0.75

Chemical Structure| 13602-82-9

[ 13602-82-9 ]

N-(2-Chloropyridin-4-yl)acetamide

Similarity: 0.73

Chemical Structure| 69008-70-4

[ 69008-70-4 ]

N,N-Dipropylpyridin-4-amine

Similarity: 0.72